Module: colorectal-path
Module Contents
- colon-clinical-treatment
1.CENTER_NO
2.PERSON_ID
3.CRC_PRIM
4.CRC1_TUMOR_NO
5.CRC1_ICD
6.CRC1_DXDATE
7.CRC1_SURG
8.CRC1_SURG_TYPE
9.CRC1_SURG_TYPE_TXT
10.CRC1_SURG_DATE
11.CRC1_SURG_LOCAL
12.CRC1_SURG_OTHORG
13.CRC1_SURG_OTHORG_SM_INTEST
14.CRC1_SURG_OTHORG_LIVER
15.CRC1_SURG_OTHORG_APPENDIX
16.CRC1_SURG_OTHORG_OVARY_NOS
17.CRC1_SURG_OTHORG_OVARY_R
18.CRC1_SURG_OTHORG_OVARY_L
19.CRC1_SURG_OTHORG_OVARY_B
20.CRC1_SURG_OTHORG_SPLEEN
21.CRC1_SURG_OTHORG_BLADDER
22.CRC1_SURG_OTHORG_OTH
23.CRC1_SURG_OTHORG_OTH_TXT
24.CRC1_SURG_MARGIN
25.CRC1_MET
26.CRC1_MET_ASCITES
27.CRC1_MET_MESEN_LN
28.CRC1_MET_LIVER
29.CRC1_MET_LUNG
30.CRC1_MET_OMENTUM
31.CRC1_MET_ABD_WALL
32.CRC1_MET_OVARY
33.CRC1_MET_BONE
34.CRC1_MET_PERITO
35.CRC1_MET_MESEN
36.CRC1_MET_OTH
37.CRC1_MET_OTH_TXT
38.CRC1_MET_RESECT
39.CRC1_MET_RESECT_DATE
40.CRC1_T
41.CRC1_N
42.CRC1_M
43.CRC1_T_SRC
44.CRC1_T_SRC_TXT
45.CRC1_N_SRC
46.CRC1_N_SRC_TXT
47.CRC1_M_SRC
48.CRC1_M_SRC_TXT
49.CRC1_CHEMO
50.CRC1_CHEMO_METHOD
51.CRC1_CHEMO1_DATE
52.CRC1_CHEMO1_AGT
53.CRC1_CHEMO1_AGT_5FU
54.CRC1_CHEMO1_AGT_FA
55.CRC1_CHEMO1_AGT_CPT11
56.CRC1_CHEMO1_AGT_OXAL
57.CRC1_CHEMO1_AGT_LEVA
58.CRC1_CHEMO1_AGT_XELO
59.CRC1_CHEMO1_AGT_AVAS
60.CRC1_CHEMO1_AGT_ERBI
61.CRC1_CHEMO1_AGT_GEMZ
62.CRC1_CHEMO1_AGT_OTH
63.CRC1_CHEMO1_AGT_OTH_TXT
64.CRC1_RAD
65.CRC1_RAD_METHOD
66.CRC1_RAD1_DATE
67.CRC1_TREAT_OTH
68.CRC1_TREAT_OTH_TXT
69.CRC1_SYNC
70.CRC1_SYNC_NUM
71.CRC1_SYNC2_TUMOR_NO
72.CRC1_SYNC2_ICD
73.CRC1_SYNC2_DXDATE
74.CRC1_SYNC2_SURG_TYPE
75.CRC1_SYNC2_SURG_TYPE_TXT
76.CRC1_SYNC2_SURG_LOCAL
77.CRC1_SYNC2_SURG_MARGIN
78.CRC1_SYNC3_TUMOR_NO
79.CRC1_SYNC3_ICD
80.CRC1_SYNC3_DXDATE
81.CRC1_SYNC3_SURG_TYPE
82.CRC1_SYNC3_SURG_TYPE_TXT
83.CRC1_SYNC3_SURG_LOCAL
84.CRC1_SYNC3_SURG_MARGIN
85.LR_RECUR
86.LR1_DATE
87.LR1_ANAST
88.LR1_MESEN
89.LR1_ABD_WALL
90.LR1_INCS
91.LR1_PELVIS
92.LR1_OTH
93.LR1_OTH_TXT
94.LR1_TREAT
95.LR1_SURG
96.LR1_SURG_LOCAL
97.LR1_SURG_TXT
98.LR1_CHEMO
99.LR1_CHEMO_METHOD
100.LR1_CHEMO1_DATE
101.LR1_CHEMO1_AGT
102.LR1_CHEMO1_AGT_5FU
103.LR1_CHEMO1_AGT_FA
104.LR1_CHEMO1_AGT_CPT11
105.LR1_CHEMO1_AGT_OXAL
106.LR1_CHEMO1_AGT_LEVA
107.LR1_CHEMO1_AGT_XELO
108.LR1_CHEMO1_AGT_AVAS
109.LR1_CHEMO1_AGT_ERBI
110.LR1_CHEMO1_AGT_GEMZ
111.LR1_CHEMO1_AGT_OTH
112.LR1_CHEMO1_AGT_OTH_TXT
113.LR1_RAD
114.LR1_RAD_METHOD
115.LR1_RAD1_DATE
116.LR1_TREAT_OTH
117.LR1_TREAT_OTH_TXT
118.LR_ADD
119.LR_ADD_ANAST
120.LR_ADD_ANAST_DATE
121.LR_ADD_MESEN
122.LR_ADD_MESEN_DATE
123.LR_ADD_ABD_WALL
124.LR_ADD_ABD_WALL_DATE
125.LR_ADD_INCS
126.LR_ADD_INCS_DATE
127.LR_ADD_PELVIS
128.LR_ADD_PELVIS_DATE
129.LR_ADD_OTH
130.LR_ADD_OTH_TXT
131.LR_ADD_OTH_DATE
132.DST_R
133.DST_R1_DATE
134.DST_R1_LIVER
135.DST_R1_LUNG
136.DST_R1_BONE
137.DST_R1_ASCITES
138.DST_R1_NONMES_LN
139.DST_R1_NONMES_LN_TXT
140.DST_R1_SUPRA_LN
141.DST_R1_BRAIN
142.DST_R1_SKIN
143.DST_R1_SKIN_TXT
144.DST_R1_ADRENAL
145.DST_R1_OTH
146.DST_R1_OTH_TXT
147.DST_R1_TREAT
148.DST_R1_SURG
149.DST_R1_SURG_LOCAL
150.DST_R1_SURG_TXT
151.DST_R1_CHEMO
152.DST_R1_CHEMO_METHOD
153.DST_R1_CHEMO1_DATE
154.DST_R1_CHEMO1_AGT
155.DST_R1_CHEMO1_AGT_5FU
156.DST_R1_CHEMO1_AGT_FA
157.DST_R1_CHEMO1_AGT_CPT11
158.DST_R1_CHEMO1_AGT_OXAL
159.DST_R1_CHEMO1_AGT_LEVA
160.DST_R1_CHEMO1_AGT_XELO
161.DST_R1_CHEMO1_AGT_AVAS
162.DST_R1_CHEMO1_AGT_ERBI
163.DST_R1_CHEMO1_AGT_GEMZ
164.DST_R1_CHEMO1_AGT_OTH
165.DST_R1_CHEMO1_AGT_OTH_TXT
166.DST_R1_RAD
167.DST_R1_RAD_METHOD
168.DST_R1_RAD1_DATE
169.DST_R_ADD
170.DST_R_ADD_LIVER
171.DST_R_ADD_LIVER_DATE
172.DST_R_ADD_LUNG
173.DST_R_ADD_LUNG_DATE
174.DST_R_ADD_BONE
175.DST_R_ADD_BONE_DATE
176.DST_R_ADD_ASCITES
177.DST_R_ADD_ASCITES_DATE
178.DST_R_ADD_NONMES_LN
179.DST_R_ADD_NONMES_LN_DATE
180.DST_R_ADD_NONMES_LN_TXT
181.DST_R_ADD_SUPRA_LN
182.DST_R_ADD_SUPRA_LN_DATE
183.DST_R_ADD_BRAIN
184.DST_R_ADD_BRAIN_DATE
185.DST_R_ADD_SKIN
186.DST_R_ADD_SKIN_DATE
187.DST_R_ADD_SKIN_TXT
188.DST_R_ADD_ADRENAL
189.DST_R_ADD_ADRENAL_DATE
190.DST_R_ADD_OTH
191.DST_R_ADD_OTH_DATE
192.DST_R_ADD_OTH_TXT
193.NEW_CRC_PRIM
194.NEW_CRC1_TUMOR_NO
195.NEW_CRC1_ICD
196.NEW_CRC1_DXDATE
197.NEW_CRC1_SURG
198.NEW_CRC1_SURG_TYPE
199.NEW_CRC1_SURG_TYPE_TXT
200.NEW_CRC1_SURG_DATE
201.NEW_CRC1_SURG_LOCAL
202.NEW_CRC1_SURG_OTHORG
203.NEW_CRC1_SURG_OTHORG_SM_INTEST
204.NEW_CRC1_SURG_OTHORG_LIVER
205.NEW_CRC1_SURG_OTHORG_APPENDIX
206.NEW_CRC1_SURG_OTHORG_OVARY_NOS
207.NEW_CRC1_SURG_OTHORG_OVARY_R
208.NEW_CRC1_SURG_OTHORG_OVARY_L
209.NEW_CRC1_SURG_OTHORG_OVARY_B
210.NEW_CRC1_SURG_OTHORG_SPLEEN
211.NEW_CRC1_SURG_OTHORG_BLADDER
212.NEW_CRC1_SURG_OTHORG_OTH
213.NEW_CRC1_SURG_OTHORG_OTH_TXT
214.NEW_CRC1_SURG_MARGIN
215.NEW_CRC1_MET
216.NEW_CRC1_MET_ASCITES
217.NEW_CRC1_MET_MESEN_LN
218.NEW_CRC1_MET_LIVER
219.NEW_CRC1_MET_LUNG
220.NEW_CRC1_MET_OMENTUM
221.NEW_CRC1_MET_ABD_WALL
222.NEW_CRC1_MET_OVARY
223.NEW_CRC1_MET_BONE
224.NEW_CRC1_MET_PERITO
225.NEW_CRC1_MET_MESEN
226.NEW_CRC1_MET_OTH
227.NEW_CRC1_MET_OTH_TXT
228.NEW_CRC1_MET_RESECT
229.NEW_CRC1_MET_RESECT_DATE
230.NEW_CRC1_T
231.NEW_CRC1_N
232.NEW_CRC1_M
233.NEW_CRC1_T_SRC
234.NEW_CRC1_T_SRC_TXT
235.NEW_CRC1_N_SRC
236.NEW_CRC1_N_SRC_TXT
237.NEW_CRC1_M_SRC
238.NEW_CRC1_M_SRC_TXT
239.NEW_CRC1_CHEMO
240.NEW_CRC1_CHEMO_METHOD
241.NEW_CRC1_CHEMO1_DATE
242.NEW_CRC1_CHEMO1_AGT
243.NEW_CRC1_CHEMO1_AGT_5FU
244.NEW_CRC1_CHEMO1_AGT_FA
245.NEW_CRC1_CHEMO1_AGT_CPT11
246.NEW_CRC1_CHEMO1_AGT_OXAL
247.NEW_CRC1_CHEMO1_AGT_LEVA
248.NEW_CRC1_CHEMO1_AGT_XELO
249.NEW_CRC1_CHEMO1_AGT_AVAS
250.NEW_CRC1_CHEMO1_AGT_ERBI
251.NEW_CRC1_CHEMO1_AGT_GEMZ
252.NEW_CRC1_CHEMO1_AGT_OTH
253.NEW_CRC1_CHEMO1_AGT_OTH_TXT
254.NEW_CRC1_RAD
255.NEW_CRC1_RAD_METHOD
256.NEW_CRC1_RAD1_DATE
257.NEW_CRC1_TREAT_OTH
258.NEW_CRC1_TREAT_OTH_TXT
259.NEW_CRC1_SYNC
260.NEW_CRC1_SYNC_NUM
261.NEW_CRC1_SYNC2_TUMOR_NO
262.NEW_CRC1_SYNC2_ICD
263.NEW_CRC1_SYNC2_DXDATE
264.NEW_CRC1_SYNC2_SURG_TYPE
265.NEW_CRC1_SYNC2_SURG_TYPE_TXT
266.NEW_CRC1_SYNC2_SURG_LOCAL
267.NEW_CRC1_SYNC2_SURG_MARGIN
268.NEW_CRC1_SYNC3_TUMOR_NO
269.NEW_CRC1_SYNC3_ICD
270.NEW_CRC1_SYNC3_DXDATE
271.NEW_CRC1_SYNC3_SURG_TYPE
272.NEW_CRC1_SYNC3_SURG_TYPE_TXT
273.NEW_CRC1_SYNC3_SURG_LOCAL
274.NEW_CRC1_SYNC3_SURG_MARGIN
275.NEW_CRC2_PRIM
276.NEW_CRC2_TUMOR_NO
277.NEW_CRC2_ICD
278.NEW_CRC2_DXDATE
279.NEW_CRC2_SURG_TYPE
280.NEW_CRC2_SURG_TYPE_TXT
281.NEW_CRC2_SURG_TYPE_LOCAL
282.NEW_CRC2_SURG_TYPE_MARGIN
283.NEW_CRC2_SYNC
284.NEW_CRC2_SYNC_NUM
285.NEW_NONCRC_PRIM
286.NEW_NONCRC1_ICD
287.NEW_NONCRC2_ICD
288.NEW_NONCRC3_ICD
289.LAST_STATUS
290.DEATH_DATE
291.DEATH_CAUSE
292.LAST_CHART_DATE
293.COMPLETE_DATE
294.LR_DST_RECUR
295.LR_DST1_ANAST
296.LR_DST1_ANAST_DATE
297.LR_DST1_MESEN
298.LR_DST1_MESEN_DATE
299.LR_DST1_ABD_WALL
300.LR_DST1_ABD_WALL_DATE
301.LR_DST1_INCS
302.LR_DST1_INCS_DATE
303.LR_DST1_PELVIS
304.LR_DST1_PELVIS_DATE
305.LR_DST1_LIVER
306.LR_DST1_LIVER_DATE
307.LR_DST1_LUNG
308.LR_DST1_LUNG_DATE
309.LR_DST1_BONE
310.LR_DST1_BONE_DATE
311.LR_DST1_ASCITES
312.LR_DST1_ASCITES_DATE
313.LR_DST1_NONMES_LN
314.LR_DST1_NONMES_LN_DATE
315.LR_DST1_NONMES_LN_TXT
316.LR_DST1_SUPRA_LN
317.LR_DST1_SUPRA_LN_DATE
318.LR_DST1_BRAIN
319.LR_DST1_BRAIN_DATE
320.LR_DST1_SKIN
321.LR_DST1_SKIN_DATE
322.LR_DST1_SKIN_TXT
323.LR_DST1_ADRENAL
324.LR_DST1_ADRENAL_DATE
325.LR_DST1_OTH
326.LR_DST1_OTH_TXT
327.LR_DST1_OTH_DATE
1 | CENTER_NO | number (2,0) | Required:true | ||||||||||||||||
Center identification number. | |||||||||||||||||||
|
2 | PERSON_ID | string (12) | Required:true |
Number that uniquely identifies an individual. |
3 | CRC_PRIM | number (1,0) | Required:true | ||||||
Primary CRC cancer diagnosed | |||||||||
|
4 | CRC1_TUMOR_NO | number (2,0) | Required:true |
PERSON_NO, TUMOR_NO uniquely identifies each tumor in the Informatics Centre. Tumor number should correspond with information from the CANCER file | |||
5 | CRC1_ICD | string (7) | Required:false |
ICD CODE: ICD0 code |
6 | CRC1_DXDATE | string (8) | Required:false | ||||||||
Diagnosis Date Of First CRC Primary(s) in the Eligibility Period: | |||||||||||
|
7 | CRC1_SURG | number (1,0) | Required:false | ||||||||||
Surgical treatment performed | |||||||||||||
|
8 | CRC1_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||
Type of surgical treatment (Can use SEER coding to derive) | |||||||||||||||||||||||||||||
|
9 | CRC1_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other surgery |
10 | CRC1_SURG_DATE | string (8) | Required:false | ||||||||
Date of 1st resection: | |||||||||||
|
11 | CRC1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings indicating completeness of excision: (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
12 | CRC1_SURG_OTHORG | number (1,0) | Required:false | ||||||||||||
Were other organs (partial or total) removed at definitive surgery? | |||||||||||||||
|
13 | CRC1_SURG_OTHORG_SM_INTEST | number (1,0) | Required:false | ||||||
If small intestine (partial or total) were removed, please specify: | |||||||||
|
14 | CRC1_SURG_OTHORG_LIVER | number (1,0) | Required:false | ||||||
If liver (partial or total) was removed, please specify: | |||||||||
|
15 | CRC1_SURG_OTHORG_APPENDIX | number (1,0) | Required:false | ||||||
If appendix (partial or total) was removed, please specify: | |||||||||
|
16 | CRC1_SURG_OTHORG_OVARY_NOS | number (1,0) | Required:false | ||||||
If ovary (partial or total) were removed and no information on which side (left or right) , please specify: | |||||||||
|
17 | CRC1_SURG_OTHORG_OVARY_R | number (1,0) | Required:false | ||||||
If right ovary (partial or total) was removed, please specify: | |||||||||
|
18 | CRC1_SURG_OTHORG_OVARY_L | number (1,0) | Required:false | ||||||
If left ovary (partial or total) was removed, please specify: | |||||||||
|
19 | CRC1_SURG_OTHORG_OVARY_B | number (1,0) | Required:false | ||||||
If both ovaries (partial or total) were removed, please specify: | |||||||||
|
20 | CRC1_SURG_OTHORG_SPLEEN | number (1,0) | Required:false | ||||||
If spleen (partial or total) was removed, please specify: | |||||||||
|
21 | CRC1_SURG_OTHORG_BLADDER | number (1,0) | Required:false | ||||||
If bladder (partial or total) was removed, please specify: | |||||||||
|
22 | CRC1_SURG_OTHORG_OTH | number (1,0) | Required:false | ||||||
If other organs (partial or total) were removed, please specify: | |||||||||
|
23 | CRC1_SURG_OTHORG_OTH_TXT | string (250) | Required:false |
Free text describing other organs (partial or total) that were removed if more than one separate with commas |
24 | CRC1_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the tumor reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
25 | CRC1_MET | number (1,0) | Required:false | ||||||||||||
Metastatic Disease Found at the time of surgery (from perative report) | |||||||||||||||
|
26 | CRC1_MET_ASCITES | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: ASCITES | |||||||||
|
27 | CRC1_MET_MESEN_LN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesenteric lymph nodes, other than in mesentery of planned resection | |||||||||
|
28 | CRC1_MET_LIVER | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Liver | |||||||||
|
29 | CRC1_MET_LUNG | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Lung | |||||||||
|
30 | CRC1_MET_OMENTUM | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Omentum | |||||||||
|
31 | CRC1_MET_ABD_WALL | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Abdominal wall | |||||||||
|
32 | CRC1_MET_OVARY | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Ovary(s) | |||||||||
|
33 | CRC1_MET_BONE | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Bone | |||||||||
|
34 | CRC1_MET_PERITO | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Peritoneum | |||||||||
|
35 | CRC1_MET_MESEN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesentery | |||||||||
|
36 | CRC1_MET_OTH | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Other | |||||||||
|
37 | CRC1_MET_OTH_TXT | string (250) | Required:false |
Free text describing other site of Metastatic Disease. If more than one separate with commas. |
38 | CRC1_MET_RESECT | number (1,0) | Required:false | ||||||||||||
Was this metastasis resected immediately (within 3 months) after baseline surgery) | |||||||||||||||
|
39 | CRC1_MET_RESECT_DATE | string (8) | Required:false | ||||||||
Date metastasis was resected (only if metastasis was completely or incompletely resected) Month of metastasis resection: Day of metastasis resection: Year of metastasis resection: | |||||||||||
|
40 | CRC1_T | number (1,0) | Required:false | ||||||||||||||||
Tumor Stage at Baseline (0-4) | |||||||||||||||||||
|
41 | CRC1_N | number (1,0) | Required:false | ||||||||||||
Nodal stage at Baseline (0-3) | |||||||||||||||
|
42 | CRC1_M | number (1,0) | Required:false | ||||||||||
Metastasis stage at Baseline (0-1) | |||||||||||||
|
43 | CRC1_T_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for tumor stage: | |||||||||||||||
|
44 | CRC1_T_SRC_TXT | string (250) | Required:false |
Source of information for tumor stage: OTHER |
45 | CRC1_N_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for nodal stage: | |||||||||||||||
|
46 | CRC1_N_SRC_TXT | string (250) | Required:false |
Source of information for nodal stage: OTHER |
47 | CRC1_M_SRC | number (1,0) | Required:false | ||||||||||||||||
Source of information for metastasis stage): | |||||||||||||||||||
|
48 | CRC1_M_SRC_TXT | string (250) | Required:false |
Source of information for metastasis stage):-OTHER |
49 | CRC1_CHEMO | number (1,0) | Required:false | ||||||||||
Was chemotherapy given for treatment of the primary colorectal cancer(s)? | |||||||||||||
|
50 | CRC1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of chemotherapy was applied for treatment of the primary colorectal cancer(s)? Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
51 | CRC1_CHEMO1_DATE | string (8) | Required:false | ||||||||
Date of 1st chemotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||||
|
52 | CRC1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall "missing/unknown agent" | |||||||||||
|
53 | CRC1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable "other" added to list additional drugs | |||||||||
|
54 | CRC1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
55 | CRC1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
56 | CRC1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
57 | CRC1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
58 | CRC1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
59 | CRC1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
60 | CRC1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
61 | CRC1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
62 | CRC1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
63 | CRC1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
NAME of OTHER AGENT, If more than one separate with commas. |
64 | CRC1_RAD | number (1,0) | Required:false | ||||||||||
Was radiation given for treatment of the primary colorectal cancer(s)? | |||||||||||||
|
65 | CRC1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the primary colorectal cancer(s)? | |||||||||||||||||
|
66 | CRC1_RAD1_DATE | string (8) | Required:false | ||||||||
Date of 1st radiotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||||
|
67 | CRC1_TREAT_OTH | number (1,0) | Required:false | ||||||||||||
Were other treatment methods applied for primary colorectal cancer(s)? | |||||||||||||||
|
68 | CRC1_TREAT_OTH_TXT | string (250) | Required:false |
Free text describing 1st other treatment. If more than one separate with commas. |
69 | CRC1_SYNC | number (1,0) | Required:false | ||||||
Were synchronous CRC primaries diagnosed at baseline? | |||||||||
|
70 | CRC1_SYNC_NUM | number (2,0) | Required:false | ||||||||
#_____ of SYNCHRONOUS PRIMARY(S) | |||||||||||
|
71 | CRC1_SYNC2_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
72 | CRC1_SYNC2_ICD | string (7) | Required:false |
ICD CODE of 2nd largest SYNCHRONOUS CRC PRIMARY (PRIMARY_2) : |
73 | CRC1_SYNC2_DXDATE | string (8) | Required:false | ||||||||
DIAGNOSIS DATE OF 2nd SYNCHRONOUS CRC PRIMARY IN THE ELIGIBILITY PERIOD | |||||||||||
|
74 | CRC1_SYNC2_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 2nd synchronous primary CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
75 | CRC1_SYNC2_SURG_TYPE_TXT | string (250) | Required:false |
Surgical treatment for 2nd synchronous primary CRC (Can use SEER coding to derive) OTHER |
76 | CRC1_SYNC2_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) for 2nd synchronous primary CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
77 | CRC1_SYNC2_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 2nd synchronous primary CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
78 | CRC1_SYNC3_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
79 | CRC1_SYNC3_ICD | string (7) | Required:false |
ICD code for 3rd largest SYNCHRONOUS CRC PRIMARY (PRIMARY_3) |
80 | CRC1_SYNC3_DXDATE | string (8) | Required:false | ||||||||
DIAGNOSIS DATE OF 3rd SYNCHRONOUS CRC PRIMARY IN THE ELIGIBILITY PERIOD | |||||||||||
|
81 | CRC1_SYNC3_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 3rd synchronous primary CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
82 | CRC1_SYNC3_SURG_TYPE_TXT | string (250) | Required:false |
Surgical treatment for 3rd synchronous primary CRC (Can use SEER coding to derive) OTHER |
83 | CRC1_SYNC3_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) for 3rd synchronous primary CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
84 | CRC1_SYNC3_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 3rd synchronous primary CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
85 | LR_RECUR | number (1,0) | Required:true | ||||||||||||
Did the patient have at least one locoregional recurrence after CRC diagnosis? (Ideally interval between diagnosis date and final chart review date should be at least 4 years) | |||||||||||||||
|
86 | LR1_DATE | string (8) | Required:false | ||||||||
Date of 1st locoregional recurrence | |||||||||||
|
87 | LR1_ANAST | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Anastomosis: | |||||||||
|
88 | LR1_MESEN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Mesentery | |||||||||
|
89 | LR1_ABD_WALL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Abdominal Wall (not incisional) | |||||||||
|
90 | LR1_INCS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Incisional | |||||||||
|
91 | LR1_PELVIS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Pelvi | |||||||||
|
92 | LR1_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): OTHER | |||||||||
|
93 | LR1_OTH_TXT | string (250) | Required:false |
LocoRegional Recurrence 1st other site Comma separated list of other site(s) |
94 | LR1_TREAT | number (1,0) | Required:false | ||||||||||
Did patient receive treatment for locoregional recurrence? | |||||||||||||
|
95 | LR1_SURG | number (1,0) | Required:false | ||||||||||
Surgical treatment given for locoregional recurrence? | |||||||||||||
|
96 | LR1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Surgery for locoregional recurrence: | |||||||||||||
|
97 | LR1_SURG_TXT | string (250) | Required:false |
If Surgery for locoregional recurrence: 1 or 2, then specify (describe procedure??text format) |
98 | LR1_CHEMO | number (1,0) | Required:false | ||||||||||
Was chemotherapy given for locoregional recurrence? | |||||||||||||
|
99 | LR1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of chemotherapy was applied for treatment of the locoregional recurrence(s) Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
100 | LR1_CHEMO1_DATE | string (8) | Required:false | ||||||||
Date of 1st chemotherapy treatment of the locoregional recurrence. | |||||||||||
|
101 | LR1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall "missing/unknown agent" | |||||||||||
|
102 | LR1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable "other" added to list additional drugs | |||||||||
|
103 | LR1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN | |||||||||
|
104 | LR1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR | |||||||||
|
105 | LR1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN | |||||||||
|
106 | LR1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE | |||||||||
|
107 | LR1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE | |||||||||
|
108 | LR1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB | |||||||||
|
109 | LR1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB | |||||||||
|
110 | LR1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR | |||||||||
|
111 | LR1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT | |||||||||
|
112 | LR1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
Free text describing OTHER CHEMOTHERAPEUTIC AGENT for first locoregional recurrence diagnosis. If more than one separate with commas. |
113 | LR1_RAD | number (1,0) | Required:false | ||||||||||
Was radiotherapy given for locoregional recurrence? | |||||||||||||
|
114 | LR1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the locoregional recurrence? | |||||||||||||||||
|
115 | LR1_RAD1_DATE | string (8) | Required:false | ||||||||
Date of 1st radiotherapy treatment of the locoregional recurrence. | |||||||||||
|
116 | LR1_TREAT_OTH | number (1,0) | Required:false | ||||||||||||
Were other treatment methods applied for first locoregional recurrence? | |||||||||||||||
|
117 | LR1_TREAT_OTH_TXT | string (250) | Required:false |
Free text describing first other treatment methods applied for first locoregional recurrence. Comma separated list of other agents(s |
118 | LR_ADD | number (1,0) | Required:false | ||||||||||||
Pseudo entry question to section on additional LR sites, ie should be yes if any LR_ADD below are yes. | |||||||||||||||
|
119 | LR_ADD_ANAST | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Anastomosis: | |||||||||
|
120 | LR_ADD_ANAST_DATE | string (8) | Required:false | ||||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||||
|
121 | LR_ADD_MESEN | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Mesentery | |||||||||
|
122 | LR_ADD_MESEN_DATE | string (8) | Required:false | ||||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||||
|
123 | LR_ADD_ABD_WALL | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Abdominal Wall (not incisional) | |||||||||
|
124 | LR_ADD_ABD_WALL_DATE | string (8) | Required:false | ||||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||||
|
125 | LR_ADD_INCS | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Incisional | |||||||||
|
126 | LR_ADD_INCS_DATE | string (8) | Required:false | ||||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||||
|
127 | LR_ADD_PELVIS | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Pelvis | |||||||||
|
128 | LR_ADD_PELVIS_DATE | string (8) | Required:false | ||||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||||
|
129 | LR_ADD_OTH | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Other | |||||||||
|
130 | LR_ADD_OTH_TXT | string (250) | Required:false |
Free text describing additional LR site |
131 | LR_ADD_OTH_DATE | string (8) | Required:false | ||||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||||
|
132 | DST_R | number (1,0) | Required:true | ||||||||||||
Did the patient have a distant recurrence after CRC diagnosis (after start date to final chart date available)? | |||||||||||||||
|
133 | DST_R1_DATE | string (8) | Required:false | ||||||||
Date of first distant recurrence | |||||||||||
|
134 | DST_R1_LIVER | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Liver | |||||||||
|
135 | DST_R1_LUNG | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Lung | |||||||||
|
136 | DST_R1_BONE | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Bone | |||||||||
|
137 | DST_R1_ASCITES | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Ascites | |||||||||
|
138 | DST_R1_NONMES_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Non mesenteric lymph nodes (except supraclavicular) | |||||||||
|
139 | DST_R1_NONMES_LN_TXT | string (250) | Required:false |
Free text describing specific non mesenteric lymph nodes (except supraclavicular) |
140 | DST_R1_SUPRA_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Supraclavicular nodes | |||||||||
|
141 | DST_R1_BRAIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Brain | |||||||||
|
142 | DST_R1_SKIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence: Skin, except incision Specify site (text): | |||||||||
|
143 | DST_R1_SKIN_TXT | string (250) | Required:false | ||||||
Free text describing specific skin site of first distant recurrence | |||||||||
|
144 | DST_R1_ADRENAL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence: Adrenal gland | |||||||||
|
145 | DST_R1_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Other Specify site (text): | |||||||||
|
146 | DST_R1_OTH_TXT | string (250) | Required:false |
Free text describing other site of first distant recurrence |
147 | DST_R1_TREAT | number (1,0) | Required:false | ||||||||||
Did the patient undergo treatment for distant recurrence?: | |||||||||||||
|
148 | DST_R1_SURG | number (1,0) | Required:false | ||||||||||
Did patient undergo surgical treatment for distant recurrence? | |||||||||||||
|
149 | DST_R1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Surgery for distant recurrence | |||||||||||||
|
150 | DST_R1_SURG_TXT | string (250) | Required:false |
Free text describing other surgery for distant recurrence 1 or 2 |
151 | DST_R1_CHEMO | number (1,0) | Required:false | ||||||||||
Did patient undergo chemotherapy for distant recurrence? | |||||||||||||
|
152 | DST_R1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
If chemotherapy was given, what method of chemotherapy was applied for treatment of the distant recurrence? Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
153 | DST_R1_CHEMO1_DATE | string (8) | Required:false | ||||||||
Date of 1st chemotherapy treatment of the distant recurrence. | |||||||||||
|
154 | DST_R1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall "missing/unknown agent | |||||||||||
|
155 | DST_R1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable "other" added to list additional drugs | |||||||||
|
156 | DST_R1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN | |||||||||
|
157 | DST_R1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR | |||||||||
|
158 | DST_R1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN | |||||||||
|
159 | DST_R1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE | |||||||||
|
160 | DST_R1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE | |||||||||
|
161 | DST_R1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB | |||||||||
|
162 | DST_R1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB | |||||||||
|
163 | DST_R1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR | |||||||||
|
164 | DST_R1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT | |||||||||
|
165 | DST_R1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
Free text describing OTHER CHEMOTHERAPEUTIC AGENT for distant recurrence diagnosis. If more than one separate with commas. |
166 | DST_R1_RAD | number (1,0) | Required:false | ||||||||||
Was radiotherapy treatment given for distant recurrence? | |||||||||||||
|
167 | DST_R1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the 1st distant recurrence? | |||||||||||||||||
|
168 | DST_R1_RAD1_DATE | string (8) | Required:false | ||||||||
Date of 1st radiotherapy treatment of the distant recurrence. | |||||||||||
|
169 | DST_R_ADD | number (1,0) | Required:false | ||||||||||||
pseudo gateway for additional distant recurrence site(s) | |||||||||||||||
|
170 | DST_R_ADD_LIVER | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Liver | |||||||||
|
171 | DST_R_ADD_LIVER_DATE | string (8) | Required:false | ||||||||
Additional Distant Recurrence First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
172 | DST_R_ADD_LUNG | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Lung | |||||||||
|
173 | DST_R_ADD_LUNG_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
174 | DST_R_ADD_BONE | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Bone | |||||||||
|
175 | DST_R_ADD_BONE_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
176 | DST_R_ADD_ASCITES | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Ascites | |||||||||
|
177 | DST_R_ADD_ASCITES_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
178 | DST_R_ADD_NONMES_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Non mesenteric lymph nodes (except supraclavicular) | |||||||||
|
179 | DST_R_ADD_NONMES_LN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
180 | DST_R_ADD_NONMES_LN_TXT | string (250) | Required:false |
Free test describing non-mesenteric lymph nodes (except supraclavicular) involved in additional distant recurrence |
181 | DST_R_ADD_SUPRA_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Supraclavicular nodes | |||||||||
|
182 | DST_R_ADD_SUPRA_LN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
183 | DST_R_ADD_BRAIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Brain | |||||||||
|
184 | DST_R_ADD_BRAIN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
185 | DST_R_ADD_SKIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Skin, except incision Specify site (text): | |||||||||
|
186 | DST_R_ADD_SKIN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
187 | DST_R_ADD_SKIN_TXT | string (250) | Required:false |
Free text describing site of additional distant recurrence in skin |
188 | DST_R_ADD_ADRENAL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Adrenal gland | |||||||||
|
189 | DST_R_ADD_ADRENAL_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
190 | DST_R_ADD_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Other Specify site (text): | |||||||||
|
191 | DST_R_ADD_OTH_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
192 | DST_R_ADD_OTH_TXT | string (250) | Required:false |
Free text describing other site of additional distant recurrence |
193 | NEW_CRC_PRIM | number (1,0) | Required:true | ||||||||||
Did the proband have a new primary colorectal cancer diagnosis after the original CRC diagnosis (after start date to final chart date)? NOTE: Additional cancer information may exist in the individual.CANCER table | |||||||||||||
|
194 | NEW_CRC1_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
195 | NEW_CRC1_ICD | string (7) | Required:false |
ICD code of 1st new CRC PRIMARY If SYNCHRONOUS primaries, please record the LARGEST. (NEW_PRIMARY_1) |
196 | NEW_CRC1_DXDATE | string (8) | Required:false | ||||||||
DIAGNOSIS DATE OF 1st New CRC PRIMARY | |||||||||||
|
197 | NEW_CRC1_SURG | number (1,0) | Required:false | ||||||||||
Surgical treatment performed for 1st New CRC PRIMARY? | |||||||||||||
|
198 | NEW_CRC1_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||
Type of surgical treatment for new CRC primary (Can use SEER coding) | |||||||||||||||||||||||||||||||||
|
199 | NEW_CRC1_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other type of surgery for 1st new CRC primary |
200 | NEW_CRC1_SURG_DATE | string (8) | Required:false | ||||||||
Date of 1st resection for 1st new CRC primary | |||||||||||
|
201 | NEW_CRC1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) for 1st new CRC primary (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
202 | NEW_CRC1_SURG_OTHORG | number (1,0) | Required:false | ||||||||||||
Were other organs (partial or total) removed at definitive surgery for 1st new CRC primary ? | |||||||||||||||
|
203 | NEW_CRC1_SURG_OTHORG_SM_INTEST | number (1,0) | Required:false | ||||||
If small intestine (partial or total) were removed, please specify: | |||||||||
|
204 | NEW_CRC1_SURG_OTHORG_LIVER | number (1,0) | Required:false | ||||||
If liver (partial or total) was removed, please specify: | |||||||||
|
205 | NEW_CRC1_SURG_OTHORG_APPENDIX | number (1,0) | Required:false | ||||||
If appendix (partial or total) was removed, please specify: | |||||||||
|
206 | NEW_CRC1_SURG_OTHORG_OVARY_NOS | number (1,0) | Required:false | ||||||
If ovary (partial or total) were removed and no information on which side (left or right) , please specify: | |||||||||
|
207 | NEW_CRC1_SURG_OTHORG_OVARY_R | number (1,0) | Required:false | ||||||
If right ovary (partial or total) was removed, please specify: | |||||||||
|
208 | NEW_CRC1_SURG_OTHORG_OVARY_L | number (1,0) | Required:false | ||||||
If left ovary (partial or total) was removed, please specify: | |||||||||
|
209 | NEW_CRC1_SURG_OTHORG_OVARY_B | number (1,0) | Required:false | ||||||
If both ovaries (partial or total) were removed, please specify: | |||||||||
|
210 | NEW_CRC1_SURG_OTHORG_SPLEEN | number (1,0) | Required:false | ||||||
If spleen (partial or total) was removed, please specify: | |||||||||
|
211 | NEW_CRC1_SURG_OTHORG_BLADDER | number (1,0) | Required:false | ||||||
If bladder (partial or total) was removed, please specify: | |||||||||
|
212 | NEW_CRC1_SURG_OTHORG_OTH | number (1,0) | Required:false | ||||||
If other organs (partial or total) were removed, please specify: | |||||||||
|
213 | NEW_CRC1_SURG_OTHORG_OTH_TXT | string (250) | Required:false |
Free text describing other organs (partial or total) removed COMMA SEPERATED IF MORE THAN ONE |
214 | NEW_CRC1_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 1st new CRC primary reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
215 | NEW_CRC1_MET | number (1,0) | Required:false | ||||||||||||
Was distant metastatic disease found at surgery for 1st new CRC primary? | |||||||||||||||
|
216 | NEW_CRC1_MET_ASCITES | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Ascites | |||||||||
|
217 | NEW_CRC1_MET_MESEN_LN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesenteric lymph nodes, other than in mesentery of planned resection | |||||||||
|
218 | NEW_CRC1_MET_LIVER | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Liver | |||||||||
|
219 | NEW_CRC1_MET_LUNG | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Lung | |||||||||
|
220 | NEW_CRC1_MET_OMENTUM | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Omentum | |||||||||
|
221 | NEW_CRC1_MET_ABD_WALL | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Abdominal wall | |||||||||
|
222 | NEW_CRC1_MET_OVARY | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Ovary(s) | |||||||||
|
223 | NEW_CRC1_MET_BONE | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Bone | |||||||||
|
224 | NEW_CRC1_MET_PERITO | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Peritoneum | |||||||||
|
225 | NEW_CRC1_MET_MESEN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesentery | |||||||||
|
226 | NEW_CRC1_MET_OTH | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Other | |||||||||
|
227 | NEW_CRC1_MET_OTH_TXT | string (250) | Required:false |
Free text describing other site of Metastatic Disease COMMA SEPERATED IF MORE THAN ONE |
228 | NEW_CRC1_MET_RESECT | number (1,0) | Required:false | ||||||||||||
Was this metastasis resected immediately (within 3 months) after baseline surgery) (if applicable) | |||||||||||||||
|
229 | NEW_CRC1_MET_RESECT_DATE | string (8) | Required:false | ||||||||
Date metastasis was resected (only if metastasis was completely or incompletely resected): | |||||||||||
|
230 | NEW_CRC1_T | number (1,0) | Required:false | ||||||||||||||||
Clinicopathologic summary stage of disease. Tumor Stage of 1st new CRC primary (0-4) | |||||||||||||||||||
|
231 | NEW_CRC1_N | number (1,0) | Required:false | ||||||||||||
Nodal stage of 1st new CRC primary (0-3) | |||||||||||||||
|
232 | NEW_CRC1_M | number (1,0) | Required:false | ||||||||||
Metastasis stage of 1st new CRC primary (0-1) | |||||||||||||
|
233 | NEW_CRC1_T_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for tumor stage: | |||||||||||||||
|
234 | NEW_CRC1_T_SRC_TXT | string (250) | Required:false |
Source of information for tumor stage: OTHER |
235 | NEW_CRC1_N_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for nodal stage: | |||||||||||||||
|
236 | NEW_CRC1_N_SRC_TXT | string (250) | Required:false |
Source of information for nodal stage: OTHER |
237 | NEW_CRC1_M_SRC | number (1,0) | Required:false | ||||||||||||||||
Source of information for metastasis stage): | |||||||||||||||||||
|
238 | NEW_CRC1_M_SRC_TXT | string (250) | Required:false |
Source of information for metastasis stage: OTHER |
239 | NEW_CRC1_CHEMO | number (1,0) | Required:false | ||||||||||
Was chemotherapy given for treatment of the new primary colorectal cancer(s)? | |||||||||||||
|
240 | NEW_CRC1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of chemotherapy was applied for treatment of the new primary colorectal cancer(s)? Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
241 | NEW_CRC1_CHEMO1_DATE | string (8) | Required:false | ||||||||
Date of 1st chemotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||||
|
242 | NEW_CRC1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall "missing/unknown agent" | |||||||||||
|
243 | NEW_CRC1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable "other" added to list additional drugs | |||||||||
|
244 | NEW_CRC1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN | |||||||||
|
245 | NEW_CRC1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR | |||||||||
|
246 | NEW_CRC1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN | |||||||||
|
247 | NEW_CRC1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE | |||||||||
|
248 | NEW_CRC1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE | |||||||||
|
249 | NEW_CRC1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB | |||||||||
|
250 | NEW_CRC1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB | |||||||||
|
251 | NEW_CRC1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR | |||||||||
|
252 | NEW_CRC1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT | |||||||||
|
253 | NEW_CRC1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
Free text describing OTHER CHEMOTHERAPEUTIC AGENT, COMMA SEPERATED IF MORE THAN ONE |
254 | NEW_CRC1_RAD | number (1,0) | Required:false | ||||||||||
Was radiation given for treatment of the new primary colorectal cancer(s)? | |||||||||||||
|
255 | NEW_CRC1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the new primary colorectal cancer(s)? | |||||||||||||||||
|
256 | NEW_CRC1_RAD1_DATE | string (8) | Required:false | ||||||||
Date of 1st radiotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||||
|
257 | NEW_CRC1_TREAT_OTH | number (1,0) | Required:false | ||||||||||
Were other treatment methods applied for new primary colorectal cancer(s)? | |||||||||||||
|
258 | NEW_CRC1_TREAT_OTH_TXT | string (250) | Required:false |
free text describing 1st other treatment methods applied for new CRC primary (NEW_CRC1_TREAT_OTH=1,2), Comma separated list of other agents(s |
259 | NEW_CRC1_SYNC | number (1,0) | Required:false | ||||||||||
Were synchronous new CRC primaries diagnosed? | |||||||||||||
|
260 | NEW_CRC1_SYNC_NUM | number (2,0) | Required:false | ||||||||
#_____ of SYNCHRONOUS PRIMARY(S) | |||||||||||
|
261 | NEW_CRC1_SYNC2_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
262 | NEW_CRC1_SYNC2_ICD | string (7) | Required:false |
ICD code of 2nd SYNCHRONOUS new CRC PRIMARY DIAGNOSIS TYPE. (Please record the 2nd largest. (NEW_PRIMARY_2) |
263 | NEW_CRC1_SYNC2_DXDATE | string (8) | Required:false | ||||||||
DIAGNOSIS DATE OF 2nd SYNCHRONOUS new CRC PRIMARY | |||||||||||
|
264 | NEW_CRC1_SYNC2_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 2nd synchronous new CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
265 | NEW_CRC1_SYNC2_SURG_TYPE_TXT | string (250) | Required:false |
free text describing other surgery for 2nd synchronous new CRC |
266 | NEW_CRC1_SYNC2_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
267 | NEW_CRC1_SYNC2_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the tumor reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
268 | NEW_CRC1_SYNC3_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
269 | NEW_CRC1_SYNC3_ICD | string (7) | Required:false |
ICD code of 3rd SYNCHRONOUS new CRC PRIMARY DIAGNOSIS TYPE. (Please record the 3rd largest. (NEW_PRIMARY_3) |
270 | NEW_CRC1_SYNC3_DXDATE | string (8) | Required:false | ||||||||
DIAGNOSIS DATE OF 3rd SYNCHRONOUS new CRC PRIMARY IN THE ELIGIBILITY PERIOD | |||||||||||
|
271 | NEW_CRC1_SYNC3_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 3rd SYNCHRONOUS new CRC primary (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
272 | NEW_CRC1_SYNC3_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other surgery for 3rd synchronous new CRC |
273 | NEW_CRC1_SYNC3_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) or 3rd synchronous new CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
274 | NEW_CRC1_SYNC3_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the or 3rd synchronous new CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
275 | NEW_CRC2_PRIM | number (1,0) | Required:false | ||||||||||
Was second "non Synchronous" CRC diagnosed within the follow-up period after the diagnosis of first new CRC? NOTE: Additional cancer information may exist in the individual.CANCER table | |||||||||||||
|
276 | NEW_CRC2_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
277 | NEW_CRC2_ICD | string (7) | Required:false |
second "non synchronous" CRC diagnosed within the follow-up period (within 4 yrs of incidence CRC) |
278 | NEW_CRC2_DXDATE | string (8) | Required:false | ||||||||
Diagnosis Date 2nd new "non-synchronous" CRC primary(s) in the follow-up period | |||||||||||
|
279 | NEW_CRC2_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 2nd non-synchronous CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
280 | NEW_CRC2_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other surgical treatment for 2nd non-synchronous CRC |
281 | NEW_CRC2_SURG_TYPE_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) 2nd non-synchronous CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
282 | NEW_CRC2_SURG_TYPE_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 2nd non-synchronous CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
283 | NEW_CRC2_SYNC | number (1,0) | Required:false | ||||||||||
Were 2nd synchronous new CRC primaries diagnosed? | |||||||||||||
|
284 | NEW_CRC2_SYNC_NUM | number (2,0) | Required:false | ||||||||
#_____ of 2nd SYNCHRONOUS PRIMARY(S) | |||||||||||
|
285 | NEW_NONCRC_PRIM | number (1,0) | Required:false | ||||||||||
Did the proband have a new non-CRC primary diagnosis after the original CRC diagnosis (after incident CRC date to date of final chart note) NOTE: Additional cancer information may exist in the individual.CANCER table | |||||||||||||
|
286 | NEW_NONCRC1_ICD | string (7) | Required:false |
ICD code for 1st new non-CRC PRIMARY |
287 | NEW_NONCRC2_ICD | string (7) | Required:false |
ICD code for 2nd new non-CRC PRIMARY |
288 | NEW_NONCRC3_ICD | string (7) | Required:false |
ICD code for 3rd new non-CRC PRIMARY |
289 | LAST_STATUS | number (1,0) | Required:true | ||||||||||||||||||||
final vital status with cause of death (COD) | |||||||||||||||||||||||
|
290 | DEATH_DATE | string (8) | Required:false | ||||||||
DATE OF DEATH | |||||||||||
|
291 | DEATH_CAUSE | string (25) | Required:false |
What was the patient??s cause of death? Cause of Death: (if known use ICD code) |
292 | LAST_CHART_DATE | string (8) | Required:false | ||||||||
Date of Last (Most Recent) Physician Chart Note found by the Abstractor (Operative Notes, Discharge Summary, Clinic Notes, Chemotherapy and/or Radiotherapy Notes) | |||||||||||
|
293 | COMPLETE_DATE | string (8) | Required:false | ||||||||
Date Form Completed (date review/abstraction completed) | |||||||||||
|
294 | LR_DST_RECUR | number (1,0) | Required:false | ||||||||||||
Did the patient have at least one locoregional or distal recurrence after CRC diagnosis? (Ideally interval between diagnosis date and final chart review date should be at least 4 years) | |||||||||||||||
|
295 | LR_DST1_ANAST | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional or distal recurrence (please circle all that apply): Anastomosis: | |||||||||
|
296 | LR_DST1_ANAST_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
297 | LR_DST1_MESEN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Mesentery | |||||||||
|
298 | LR_DST1_MESEN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
299 | LR_DST1_ABD_WALL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Abdominal Wall (not incisional) | |||||||||
|
300 | LR_DST1_ABD_WALL_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
301 | LR_DST1_INCS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Incisional | |||||||||
|
302 | LR_DST1_INCS_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
303 | LR_DST1_PELVIS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distal or locoregional recurrence (please circle all that apply): Pelvis | |||||||||
|
304 | LR_DST1_PELVIS_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
305 | LR_DST1_LIVER | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Liver | |||||||||
|
306 | LR_DST1_LIVER_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
307 | LR_DST1_LUNG | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Lung | |||||||||
|
308 | LR_DST1_LUNG_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
309 | LR_DST1_BONE | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Bone | |||||||||
|
310 | LR_DST1_BONE_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
311 | LR_DST1_ASCITES | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Ascites | |||||||||
|
312 | LR_DST1_ASCITES_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
313 | LR_DST1_NONMES_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Non-mesenteric lymph nodes (except supraclavicular) | |||||||||
|
314 | LR_DST1_NONMES_LN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
315 | LR_DST1_NONMES_LN_TXT | string (250) | Required:false |
Free text describing specific non-mesenteric lymph nodes (except supraclavicular) |
316 | LR_DST1_SUPRA_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Supraclavicular nodes | |||||||||
|
317 | LR_DST1_SUPRA_LN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
318 | LR_DST1_BRAIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Brain | |||||||||
|
319 | LR_DST1_BRAIN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
320 | LR_DST1_SKIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence: Skin, except incision Specify site (text): | |||||||||
|
321 | LR_DST1_SKIN_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
322 | LR_DST1_SKIN_TXT | string (250) | Required:false |
Free text describing first distant or locoregional recurrence in skin, except incision |
323 | LR_DST1_ADRENAL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence: Adrenal gland | |||||||||
|
324 | LR_DST1_ADRENAL_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|
325 | LR_DST1_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Other Specify site (text): | |||||||||
|
326 | LR_DST1_OTH_TXT | string (250) | Required:false |
Free text describing other site of first distant or locoregional recurrence |
327 | LR_DST1_OTH_DATE | string (8) | Required:false | ||||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||||
|